About Research at UPMC Hillman Cancer Center

UPMC Hillman Cancer Center is a National Cancer Institute (NCI)-designated Comprehensive Cancer Center - a highly prestigious classification for cancer centers in the U.S. We are the preeminent institution in western Pennsylvania for providing cancer care; conducting basic, translational, clinical, and population science research; and educating the next generation of cancer researchers and physicians.

We have more than 300 researchers who collaborate with our clinicians to advance the most promising laboratory studies into novel clinical trials in order to provide patients with early access to new and innovative treatments.

The nationally and internationally renowned research at UPMC Hillman Cancer Center includes a range of disciplines, from cancer prevention and early detection to novel therapeutic discovery, survivorship, and end-of-life care.

We are also dedicated to the education and training of the next generation of cancer researchers and physicians, as well as the ongoing recruitment of world-renowned scientists.

As the only NCI-designated Comprehensive Cancer Center in western Pennsylvania, UPMC Hillman Cancer Center is dedicated to excellence for our patients, and we are working to make vast strides in the global effort to reduce the burden of cancer.